TCG Crossover Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,912,861
Closed -$5.16M 35
2023
Q4
$5.16M Sell
2,912,861
-8,198,250
-74% -$14.5M 0.57% 27
2023
Q3
$35.1M Buy
+11,111,111
New +$35.1M 5.17% 6